MedInfo World

Empowering patients through shared knowledge and community-driven health insights.

Platform

Drug Information
Health Conditions
Active Ingredients

Support

Help Center
Terms of Use
Privacy Policy
Disclaimer

Company

About Us
Contact

Medical Disclaimer

The information on this website is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Terms Privacy Disclaimer

Ocrelizumab – Uses, Side Effects, Dosage & Drug Information | MedInfo World | MedInfo World

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.

Home Active IngredientsOcrelizumab

Ocrelizumab

CD20-directed Cytolytic Antibody [EPC]

2 Drugs2 Variants

Clinical Data

Name

Ocrelizumab

Raw Name

OCRELIZUMAB

Drug Classes

CD20-directed Cytolytic Antibody [EPC]Endoglycosidase [EPC]

Important Notice

This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Ocrelizumab.

Mechanism of Action

CD20-directed Antibody Interactions [MoA]

Chemical Structure

Antibodies, Monoclonal [CS]Antibodies, Monoclonal, Humanized [CS]Glycoside Hydrolases [CS]

Identifiers

RxCUI

1876380, 1876385, 2693458, 2693465

UNII

A10SJL62JY, 743QUY4VD8

Drugs with Ocrelizumab

Medications containing this ingredient

Ocrevus